Our data showed a trend toward longer PFS in the G‐CSF received group compared to that in the G‐CSF not received group (Figure 4a,c,d ).
← all excerpts
Efficacy and safety of carboplatin and etoposide in older extensive-stage small-cell lung cancer patients with a poor performance status.
1
—
—